EG110A is an investigational DNA medicine under development for neurogenic detrusor overactivity with urinary incontinence.

Andrew Peterson, MD, discusses the quality-of-life impact of post-cancer incontinence and advances in electronically controlled artificial urinary sphincters.

A recap of the FDA submissions and regulatory decisions in urology from August 2026.

Marian Cuello joins to discuss sexual wellness and the importance of normalizing conversations about sexual health for all individuals.

Eugene Cone, MD, discusses SWOG S1602 findings comparing Tokyo-172 and TICE BCG and the potential role of alternative BCG strains in NMIBC

Juan Gómez-Rivas, MD, discusses barriers to PSMA-PET imaging and how disparities in access may affect prostate cancer staging and treatment planning.

The clearance expands access to the LigaSure vessel-sealing technology within robotic surgical workflows.

Early neurophysiology and pressure-flow research directly underpin modern urodynamics, whereas Turner-Warwick's restorative philosophy, according to Sasha Vereecken, BScN, RN.